orbax- orbifloxacin tablet, coated
merck sharp & dohme corp. - orbifloxacin (unii: 660932tpy6) (orbifloxacin - unii:660932tpy6) - orbifloxacin 22.7 mg - indications: orbax® (orbifloxacin) tablets are indicated for the management of diseases in dogs and cats associated with bacteria susceptible to orbifloxacin. contraindications: orbifloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. orbifloxacin is contraindicated in immature dogs during the rapid growth phase (between 2 and 8 months of age in small and medium-sized breeds, and up to 18 months of age in large and giant breeds). orbifloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.
moxifloxacina 400 mg tabletas recubiertas.
laboratorios la santÉ, s.a. - moxifloxacina (clorhidrato) - moxifloxacina (clorhidrato) ....400.00 mg
pradofloxacin
elanco australasia pty ltd - pradofloxacin - unknown - pradofloxacin antibiotic active 0.0 - active constituent
orbax- orbifloxacin suspension
merck sharp & dohme corp - orbifloxacin (unii: 660932tpy6) (orbifloxacin - unii:660932tpy6) - orbifloxacin 30 mg in 1 ml - indications: orbax® oral suspension is indicated for the treatment of urinary tract infections (cystitis) in dogs caused by susceptible strains of staphylococcus pseudintermedius, proteus mirabilis, escherichia coli and enterococcus faecalis . orbax® oral suspension is also indicated for skin and soft tissue infections (wounds and abscesses) in dogs caused by susceptible strains of staphylococcus pseudintermedius, staphylococcus aureus , coagulase positive staphylococci, pasteurella multocida, proteus mirabilis, pseudomonas spp., klebsiella pneumoniae, escherichia coli, enterobacter spp., citrobacter spp., enterococcus faecalis , β-hemolytic streptococci (group g) and streptococcus equisimilis . contraindications: orbifloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. orbifloxacin is contraindicated in immature dogs during the rapid growth phase (between 2 and 8 months of age
veraflox- pradofloxacin suspension
bayer healthcare llc animal health division - pradofloxacin (unii: 6o0t5e048i) (pradofloxacin - unii:6o0t5e048i) - pradofloxacin 25 mg in 1 ml - veraflox is indicated for the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of pasteurella multocida, streptococcus canis, staphylococcus aureus, staphylococcus felis, and staphylococcus pseudintermedius. do not use in dogs. pradofloxacin has been shown to cause bone marrow suppression in dogs. dogs may be particularly sensitive to this effect, potentially resulting in severe thrombocytopenia and neutropenia. quinolone-class drugs have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. pradofloxacin is contraindicated in cats with a known hypersensitivity to quinolones.
orbax 25 mg tablets for dogs and cats
intervet australia pty limited - orbifloxacin - oral tablet - orbifloxacin antibiotic active 25.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - acinetobacter spp. | enterobacter spp. | enterococcus faecalis | escherichia coli (e. coli) | klebsiella pneumoniae | pasteurella multocida | proteus mirabilis | pseudomonas spp. | staphylococcus intermedius | streptococcus - hemolytic group g | deep pyodermas | fowl cholera | including b-lactamase producin | including secondary invaders | seborrhoeic dermatitis
orbax 6.25 mg tablets for dogs and cats
intervet australia pty limited - orbifloxacin - oral tablet - orbifloxacin antibiotic active 6.25 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - acinetobacter spp. | enterobacter spp. | enterococcus faecalis | escherichia coli (e. coli) | klebsiella pneumoniae | pasteurella multocida | proteus mirabilis | pseudomonas spp. | staphylococcus intermedius | streptococcus - hemolytic group g | deep pyodermas | fowl cholera | including b-lactamase producin | including secondary invaders | seborrhoeic dermatitis
orbax 75 mg tablets for dogs and cats
intervet australia pty limited - orbifloxacin - oral tablet - orbifloxacin antibiotic active 75.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - acinetobacter spp. | enterobacter spp. | enterococcus faecalis | escherichia coli (e. coli) | klebsiella pneumoniae | pasteurella multocida | proteus mirabilis | pseudomonas spp. | staphylococcus intermedius | streptococcus - hemolytic group g | deep pyodermas | fowl cholera | including b-lactamase producin | including secondary invaders | seborrhoeic dermatitis
orbifloxacin powder
katayama seiyakusyo co., ltd. - orbifloxacin (unii: 660932tpy6) (orbifloxacin - unii:660932tpy6) -
orbifloxacin powder
sumitomo dainippon pharma co., ltd. - orbifloxacin (unii: 660932tpy6) (orbifloxacin - unii:660932tpy6) -